Literature DB >> 194694

Phase II clinical trial of weekly administration of VP-16-213 in small cell bronchogenic carcinoma.

M H Cohen, L E Broder, B E Fossieck, D C Ihde, J D Minna.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 194694

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  10 in total

1.  Clinical pharmacology of intracarotid etoposide.

Authors:  N Savaraj; L G Feun; K Lu; S Wallace; W S Fields; T L Loo
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

Review 2.  Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention.

Authors:  V B Pai; M C Nahata
Journal:  Drug Saf       Date:  2000-04       Impact factor: 5.606

Review 3.  The podophyllotoxin derivatives VP16-213 and VM26.

Authors:  B F Issell
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

4.  Cyclic alternating combination chemotherapy for small cell lung cancer.

Authors:  S K Reddy; H Takita; W W Lane; R G Vincent; T Y Chen; J E Caracandas; A M Regal
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

5.  Epipodophyllotoxin (VP16-213) in small cell carcinoma of the Bronchus resistant to initial combination chemotherapy.

Authors:  P G Harper; M B Dally; D M Geddes; S G Spiro; J F Smyth; R L Souhami
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

Review 6.  Podophyllotoxin derivative VP 16-213.

Authors:  A M Arnold
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

7.  [Etoposide VP 16--213)--a podophyllotoxinderivative with high antitumor activity (author's transl)].

Authors:  H J Schmoll; N Niederle; W Achterrath
Journal:  Klin Wochenschr       Date:  1981-11-02

8.  Safety and efficacy of intraperitoneal injection of etoposide in oil suspension in mice with peritoneal carcinomatosis.

Authors:  J S Lee; T Takahashi; A Hagiwara; C Yoneyama; M Itoh; T Sasabe; S Muranishi; S Tashima
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

Review 9.  Cancer therapy and cardiotoxicity: the need of serial Doppler echocardiography.

Authors:  Maurizio Galderisi; Francesco Marra; Roberta Esposito; Vincenzo Schiano Lomoriello; Moira Pardo; Oreste de Divitiis
Journal:  Cardiovasc Ultrasound       Date:  2007-01-25       Impact factor: 2.062

10.  Cell death mechanisms of the anti-cancer drug etoposide on human cardiomyocytes isolated from pluripotent stem cells.

Authors:  Harshal Nemade; Umesh Chaudhari; Aviseka Acharya; Jürgen Hescheler; Jan Georg Hengstler; Symeon Papadopoulos; Agapios Sachinidis
Journal:  Arch Toxicol       Date:  2018-02-03       Impact factor: 5.153
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.